Roche Holding AG Virtual Event on Key Ophthalmology Data Presented at the Angiogenesis 2021 Meeting Transcript
(technical difficulty) Angiogenesis 2021 Webinar. My name is Henrik, and I'm the technical operator for today's call. Kindly note that the webinar is being recorded. (Operator Instructions)
At this time, it's my pleasure to introduce you to Karl Mahler, Head of Investor Relations and Group Planning. Karl, the stage is yours.
Yes. Thanks a lot, Henrik. I can see that you have a strong interest in the call. I think we have -- you told me, Henrik, that it will be about 250 people minimum preregistered, so high interest. Thanks for your interest in our ophthalmology franchise. I hope that you're all safe and well.
We have basically 1 hour to discuss our data, 30 minutes from our side on presentation, 30 minutes Q&A. This is a Zoom call. You can raise your hand, as Henrik explained. We will have the telephone line. I can see that we already have 5 participants raise the hand. (Operator Instructions) And of course, you also can send me an email if you want, [email protected]. Then I will read your
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |